1-855-378-42281-855-378-4228
One of the out-patient rehab alternatives for clients in Balcones Heights who are struggling with opioid abuse and addiction is opioid maintenance therapy. Some centers and doctors are authorized to administer specific medications to opioid addicted people, many of which are opioids themselves and are addictive. In low enough amounts the client doesn't feel high but also doesn't have intense cravings and is not experiencing opioid withdrawal. Methadone is the first drug tried for this purpose, but there are a few more choices to pick from.
Methadone is an opiate and can be taken at an outpatient medical center certified to dispense the med, which is taken on a daily basis as a pill or liquid. The price of the med is approximately one hundred and fifty dolloars a month. Buprenorphine is also an opioid based drug, and is a pill often taken one day on, one day off. But different from Methadone that can only be given in highly well-regulated medical centers, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is around just under $300 monthly for the generic of the medication. There is also a type of buprenorphine that contains the ingredient naloxone, that is a drug which blocks the effects of opioids. An individual consuming this version of the drug, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken every day, and costs around $450 per month. Naltrexone is another med used in opioid maintenance therapy, but unlike the other medications mentioned here it is an opiate blocker and is not an opioid. There is an option to take this drug as a monthly injection, and that is called Vivitrol. As an opioid blocker, the drug prevents a person from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs in the range of $1000 to $1200 per month.
For All Drug and Alcohol Treatment Programs In Balcones Heights, Click Here.
